These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 37600019)

  • 61. Microbiota-Immune System Interactions in Human Neurological Disorders.
    Huang Q; Yu F; Liao D; Xia J
    CNS Neurol Disord Drug Targets; 2020; 19(7):509-526. PubMed ID: 32713337
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Microbiota-Gut-Brain Axis.
    Cryan JF; O'Riordan KJ; Cowan CSM; Sandhu KV; Bastiaanssen TFS; Boehme M; Codagnone MG; Cussotto S; Fulling C; Golubeva AV; Guzzetta KE; Jaggar M; Long-Smith CM; Lyte JM; Martin JA; Molinero-Perez A; Moloney G; Morelli E; Morillas E; O'Connor R; Cruz-Pereira JS; Peterson VL; Rea K; Ritz NL; Sherwin E; Spichak S; Teichman EM; van de Wouw M; Ventura-Silva AP; Wallace-Fitzsimons SE; Hyland N; Clarke G; Dinan TG
    Physiol Rev; 2019 Oct; 99(4):1877-2013. PubMed ID: 31460832
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gut Microbiota as a Mediator of Host Neuro-Immune Interactions: Implications in Neuroinflammatory Disorders.
    Caputi V; Popov J; Giron MC; O Apos Mahony S
    Mod Trends Psychiatry; 2021; 32():40-57. PubMed ID: 34032644
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The gut-immune-brain axis in neurodevelopment and neurological disorders.
    Park JC; Im SH
    Microbiome Res Rep; 2022; 1(4):23. PubMed ID: 38046904
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
    Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
    Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
    Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications.
    Jain A; Madkan S; Patil P
    Cureus; 2023 Oct; 15(10):e47861. PubMed ID: 38022117
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis.
    Ullah H; Tovchiga O; Daglia M; Khan H
    Curr Neuropharmacol; 2021; 19(11):1966-1983. PubMed ID: 33596808
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer's Disease.
    Wang Y
    CNS Neurol Disord Drug Targets; 2023; 22(4):577-598. PubMed ID: 35440320
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Brain-gut-microbiota axis in Parkinson's disease: A historical review and future perspective.
    Dong S; Sun M; He C; Cheng H
    Brain Res Bull; 2022 Jun; 183():84-93. PubMed ID: 35245613
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review.
    Barrio C; Arias-Sánchez S; Martín-Monzón I
    Psychoneuroendocrinology; 2022 Mar; 137():105640. PubMed ID: 34942539
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of vitamin deficiency on microbiota composition and immunomodulation: relevance to autistic spectrum disorders.
    Ribeiro R; Nicoli JR; Santos G; Lima-Santos J
    Nutr Neurosci; 2021 Aug; 24(8):601-613. PubMed ID: 31506005
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A narrative review of relationship between gut microbiota and neuropsychiatric disorders: mechanisms and clinical application of probiotics and prebiotics.
    Yang H; Liu Y; Cai R; Li Y; Gu B
    Ann Palliat Med; 2021 Feb; 10(2):2304-2313. PubMed ID: 33549028
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder.
    Li Q; Zhou JM
    Neuroscience; 2016 Jun; 324():131-9. PubMed ID: 26964681
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The microbiota-immune axis as a central mediator of gut-brain communication.
    Fung TC
    Neurobiol Dis; 2020 Mar; 136():104714. PubMed ID: 31846737
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dysbiosis and Alzheimer's Disease: Cause or Treatment Opportunity?
    Janeiro MH; Ramírez MJ; Solas M
    Cell Mol Neurobiol; 2022 Mar; 42(2):377-387. PubMed ID: 33400081
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of the Gut-Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson's Disease.
    Thangaleela S; Sivamaruthi BS; Kesika P; Bharathi M; Chaiyasut C
    Microorganisms; 2022 Jul; 10(8):. PubMed ID: 36013962
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of Probiotics and Diet in the Management of Neurological Diseases and Mood States: A Review.
    Thangaleela S; Sivamaruthi BS; Kesika P; Chaiyasut C
    Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36422338
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of the microbiota-gut-brain axis in neuropsychiatric disorders.
    Generoso JS; Giridharan VV; Lee J; Macedo D; Barichello T
    Braz J Psychiatry; 2021; 43(3):293-305. PubMed ID: 32667590
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The molecular signaling of exercise and obesity in the microbiota-gut-brain axis.
    Ribeiro FM; Silva MA; Lyssa V; Marques G; Lima HK; Franco OL; Petriz B
    Front Endocrinol (Lausanne); 2022; 13():927170. PubMed ID: 35966101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.